826 abstracts found.



Results filter

HER-2 expression has no adverse prognostic signficance in caucasian patients with gastro-oesophageal adenocarcinomas: Analysis of Brightfield double In Situ hybridisation (BDISH) for HER-2 gene amplification and immunohistochemistry for HER-2 protein expression

Year:

Session type:

Michelle Cunnell (1), Alex Reecesmith (2), Irshad Soomro (3), Zia Chaudry (3), Ian Ellis (3), Simon Parsons (2), Srinivasan Madhusudan (1)
Academic Unit of Oncology, School of Molecular Medical Sciences, Faculty of Medicine & Health Sciences, University of Nottingham, Nottingham University Hospitals, Nottingham, United Kingdom (1), Department of Surgery, Nottingham University Hospitals, Nottingham, United Kingdom (2), Department of Pathology, Nottingham University Hospitals, Nottingham, United Kingdom (3)

P-cadherin identifies cells with stem-like properties in basal-like breast cancer

Year:

Session type:

Andre F Vieira (1), Sara Ricardo (1), Matthew Ablett (2), Raquel Seruca (3), Fernando Schmitt (3), Robert B Clarke (2), Joana Paredes (1)
Institute of Molecular Pathology and Immunology of the University of Porto, Porto, Portugal (1), Paterson Institute for Cancer Research, Manchester, United Kingdom (2), Medical Faculty of the University of Porto, Porto, Portugal (3)

Akt interacts with DNA-PKcs for optimal DNA damage repair

Year:

Session type:

Mahmoud Toulany (1), H. Peter Rodemann (1)
Division of Radiobiology and Molecular Environmental Research, Department of Radiation Oncology, Eberhard-Karls University Tuebingen, Tuebingen, Germany (1)

P14ARF-p53 induced senescence revisited: protector or precursor of latent breast cancer?

Year:

Session type:

Eileen McGowan (1), Daniel Yagoub (2), Nikki Alling (3)
Centenary, Sydney, Australia (1), University of Sydney, Sydney, Australia (2), Royal Prince Alfred Hospital, Sydney, Australia (3), Garvan Institute of Medical Research, Sydney, Australia (4)

Decreased expression of high molecular weight Tropomyosins in Squamous Cell Carcinoma of Esophagus (SCCE) 

Year:

Session type:

Maryam Zare (1), Ferdous Rastgar Jazii (1), Zahra- Soheila Soheili (1)
Biochemistry department, National Institute of Genetic Engineering & Biotechnology (NIGEB), Tehran, Iran, Islamic Republic of (1)

The role of CYP2C40 and CYP2C55 in colon cancer

Year:

Session type:

Michael Albert (1), Andrew Bennett (1)
Nottingham University School of Biomedical Sciences, Nottingham, United Kingdom (1)

CDKI-83?a novel CDK9 inhibitor as a potent anti-tumour agent

Year:

Session type:

Shenhua Shi (1), Frankie Lam (1), Xiangrui Liu (1), Shudong Wang (1)
University of Nottingham, Nottingham, United Kingdom (1)

Tetrahydrobiopterin synthesis in cancer-associated fibroblasts promotes tumour angiogenesis and progression

Year:

Session type:

Xin Zeng (1), Liye Chen (1), Michael Presz (1), Simon Briggs (1), Russell leek (1), Gillies McKenna (1), Adrian Harris (1), Shijie Cai (1)
University of Oxford, Oxford, United Kingdom (1)

Combination therapy with an Aurora B kinase inhibitor AZD1152 and AraC, shows enhanced tumouricidal activity in a preclinical model of acute myeloid leukaemia (AML)

Year:

Session type:

Rajesh Odedra (1), Robert W. Wilkinson (1), Sarah V. Holt (2), John R. Foster (1), Elizabeth Anderson (1)
AstraZeneca, Alderley Park, United Kingdom (1), Paterson Institute of Cancer Research, Manchester, United Kingdom (2)

Structural characterisation of human mitotic kinesin – KIF15

Year:

Session type:

Marta Kozlowska (1), Venkatasubramanian Ulaganathan (1), Frank Kozielski (1)
The Beatson Institute for Cancer Research, Glasgow, United Kingdom (1)

Page 2 of 83« First...2...25...Last »